Sherbrooke Park Advisers LLC Kura Oncology, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $230 Billion
- Q2 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 18,619 shares of KURA stock, worth $194,382. This represents 0.05% of its overall portfolio holdings.
Number of Shares
18,619
Previous 40,024
53.48%
Holding current value
$194,382
Previous $264 Million
59.33%
% of portfolio
0.05%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding KURA
# of Institutions
200Shares Held
80.6MCall Options Held
53.6KPut Options Held
42.8K-
Suvretta Capital Management, LLC New York, NY8.12MShares$84.7 Million1.61% of portfolio
-
Bvf Inc San Francisco, CA7.75MShares$81 Million1.76% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$72.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.2MShares$64.7 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$55.8 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $698M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...